Emodin suppressed TGF-β1 production in BC cells and macrophages and attenuated TGF-β1 or macrophage-induced epithelial–mesenchymal transition (EMT) and cancer stem cell (CSC) formation of BC cells. This evidence concerns the gene TGFB1 and breast cancer.